CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websitepappasventures.com
Phone919-998-3300
Employees

Funds

Offices

Durham, USA
2520 Meridian Parkway Suite 400
Durham, NC, 27713
USA
Mailing address
P. O. Box 110287
Research Triangle Park, NC, 27709
USA

People

Managing Partner
Partner

Tags

Pappas Ventures

At Pappas Ventures, their sole focus is investing in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Their success, however, is not simply a product of investment capital. They bring experience, creativity and passion to each and every partnership. And in so doing, they are bringing promising technologies to commercial application – from concept to commerce.

Milestones

Investments

Company Date Round Size Participants
CeNeRx BioPharma 2/12Series D$4.6M3
CoLucid Pharmaceuticals 8/11Venture Round$7.5M5
TESARO 6/11Series B$101M5
Ultragenyx Pharmaceutical 6/11Series A$45M4
Milestone Pharmaceuticals 6/11Venture Round$13M3
CardioDx 5/11Venture Round$60M13
Chimerix 2/11Series F$45M8
TyRx Pharma 12/10Venture Round$20M3
Achillion Pharmaceuticals 8/10Venture Round$50.1M4
CeNeRx BioPharma 8/10Series C$13M3
Liquidia Technologies 7/10Series C$5M5
CardioDx 5/10Series D$34.5M8
Syndax Pharmaceuticals 3/10Series A$9M5
Liquidia Technologies 1/10Series C$20M5
Afferent Pharmaceuticals 12/09Series A$23M4
Barosense 8/09Series D$27M7
Biosyntech 8/09Venture Round$1.4M4
BrainCells 3/08Series B$30M6
LEAD Therapeutics 11/07Series A$17M3
FlowCardia 8/07Series C$30M9
Gentis 6/07Series A$10M4
Cequent Pharmaceuticals 6/07Series A$9M4

Videos

Sources

  1. CeNeRx BioPharma, Inc.: Series D $4.6M (onbiovc.com) [edit]
  2. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million (prnewswire.com) [edit]
  3. TESARO Secures $101M in Series B Financing (finsmes.com) [edit]
  4. Ultragenyx Pharmaceutical Closes $45M Series A Financing (finsmes.com) [edit]
  5. Milestone Pharmaceuticals Announces $13 Million Equity Financing (money.msn.com) [edit]
  6. CardioDx Closes $60m Financing Round (finsmes.com) [edit]
  7. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 (chimerix-inc.com) [edit]
  8. TYRX, Inc. Raises $20 Million in Private Financing (tyrx.com) [edit]
  9. Achillion Announces Private Placement of $50 Million (ir.achillion.com) [edit]
  10. CENERX BIOPHARMA COMPLETES $13 MILLION SERIES C FINANCING (cenerx.com) [edit]
  11. Liquidia Technologies, Inc.: Series C $5M (onbiovc.com) [edit]
  12. CardioDx, Inc.: Series D $34.5M (onbiovc.com) [edit]
  13. Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]
  14. Liquidia Technologies Raises $20M in Series C Financing (finsmes.com) [edit]
  15. Afferent Pharmaceuticals Closes $23M Series A Financing Round (finsmes.com) [edit]
  16. Barosense bags $27M for obesity treatment (deals.venturebeat.com) [edit]
  17. BioSyntech Announces $4.5 Million Financing (biosyntech.com) [edit]
  18. BrainCells raises $30M (venturebeat.com) [edit]
  19. LEAD Therapeutics Raises $17 Million in Series A Financing (leadtherapeutics.com) [edit]
  20. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
  21. Gentis raises $10M for spine-injected implants (venturebeat.com) [edit]
  22. Cequent Pharmaceuticals (cequentpharma.com) [edit]
Edit This Page
Last Edited 2/3/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy